Literature DB >> 19842981

Topical antimicrobial therapy for treating chronic wounds.

Benjamin A Lipsky1, Christopher Hoey.   

Abstract

Various agents have been applied topically to treat infected wounds for millennia, but their proper role remains unclear. Topical therapy affords many potential advantages but also has disadvantages. Opinions differ on which clinical signs define wound infection and on whether quantitative microbiological studies are useful. Clinically infected wounds usually require systemic antibiotic therapy, whereas clinically uninfected wounds that are healing as expected do not require antimicrobials. There is controversy over how to treat poorly healing wounds with "secondary" signs suggesting infection; these may benefit from topical antimicrobial agents. Some evidence supports using topical agents for malodorous or burn wounds. Meta-analyses and systematic reviews suggest there are few proven indications for topical antimicrobials. Use of a newer, relatively nontoxic antiseptic (eg, cadexomer iodine or silver dressings) is preferable to use of topical antibiotics, especially agents that are available for systemic use. We provide clinically relevant information on currently available topical antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19842981     DOI: 10.1086/644732

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  105 in total

1.  Nitric oxide nanoparticle technology: a novel antimicrobial agent in the context of current treatment of skin and soft tissue infection.

Authors:  Laura Englander; Adam Friedman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

2.  Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo.

Authors:  Gilles Brackman; Paul Cos; Louis Maes; Hans J Nelis; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

Review 3.  Topical antimicrobial agents for treating foot ulcers in people with diabetes.

Authors:  Jo C Dumville; Benjamin A Lipsky; Christopher Hoey; Mario Cruciani; Marta Fiscon; Jun Xia
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

4.  In vitro cellular viability studies on a concentrated surfactant-based wound dressing.

Authors:  Rui Chen; Anne-Marie Salisbury; Steven L Percival
Journal:  Int Wound J       Date:  2019-03-20       Impact factor: 3.315

5.  Biofilms and delayed healing - an in vitro evaluation of silver- and iodine-containing dressings and their effect on bacterial and human cells.

Authors:  Katie A Bourdillon; Craig P Delury; Breda M Cullen
Journal:  Int Wound J       Date:  2017-05-14       Impact factor: 3.315

6.  The Role of Topical Antiseptic Agents Within Antimicrobial Stewardship Strategies for Prevention and Treatment of Surgical Site and Chronic Open Wound Infection.

Authors:  Christopher D Roberts; David J Leaper; Ojan Assadian
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-02-01       Impact factor: 4.730

Review 7.  New Molecular Techniques to Study the Skin Microbiota of Diabetic Foot Ulcers.

Authors:  Jean-Philippe Lavigne; Albert Sotto; Catherine Dunyach-Remy; Benjamin A Lipsky
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-01-01       Impact factor: 4.730

Review 8.  Multifunctional Biomedical Adhesives.

Authors:  Rattapol Pinnaratip; Mohammad Saleh Akram Bhuiyan; Kaylee Meyers; Rupak M Rajachar; Bruce P Lee
Journal:  Adv Healthc Mater       Date:  2019-04-03       Impact factor: 9.933

Review 9.  Treatment Options to Manage Wound Biofilm.

Authors:  Curtis E Jones; John P Kennedy
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-06       Impact factor: 4.730

Review 10.  Silver nanoparticles as real topical bullets for wound healing.

Authors:  Thirumurugan Gunasekaran; Tadele Nigusse; Magharla Dasaratha Dhanaraju
Journal:  J Am Coll Clin Wound Spec       Date:  2012-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.